Myeloid derived suppressor cells and their role in tolerance induction in cancer
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
期刊
JOURNAL OF DERMATOLOGICAL SCIENCE
卷 59, 期 1, 页码 1-6出版社
ELSEVIER IRELAND LTD
关键词
类别
作者
我是这篇论文的作者
推荐
CD66b+monocytes represent a proinflammatory myeloid subpopulation in cancer
Utku Horzum, Digdem Yoyen-Ermis, Ekim Z. Taskiran, Kerim Bora Yilmaz, Erhan Hamaloglu, Derya Karakoc, Gunes Esendagli
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Ovarian Cancer Metastasis
Yichen Li, Qian Zhang, Mandi Wu, Peidong Zhang, Liang Huang, Xiaolin Ai, Zhengnan Yang, Qiuhong Shen, Yiran Wang, Ping Wang, Shengtao Zhou, Ming-Liang He
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts
Laxminarasimha Donthireddy, Prashanthi Vonteddu, Tushar Murthy, Taekyoung Kwak, Rukiye-Nazan Eraslan, Joseph R. Podojil, Adam Elhofy, Michael T. Boyne, John J. Puisis, Filippo Veglia, Surya S. Singh, Farokh Dotiwala, Luis J. Montaner, Dmitry Gabrilovich
JOURNAL OF CANCER (2022)
The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice
Megan T. Hoffman, Samantha B. Kemp, Daniel J. Salas-Escabillas, Yaqing Zhang, Nina G. Steele, Stephanie The, Daniel Long, Simone Benitz, Wei Yan, Robert F. Margolskee, Filip Bednar, Marina Pasca di Magliano, Hui-Ju Wen, Howard C. Crawford
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
Steven H. Sun, Brooke Benner, Himanshu Savardekar, Gabriella Lapurga, Logan Good, David Abood, Erin Nagle, Megan Duggan, Andrew Stiff, Mallory J. DiVincenzo, Lorena P. Suarez-Kelly, Amanda Campbell, Lianbo Yu, Robert Wesolowski, Harrison Howard, Hiral Shah, Kari Kendra, William E. Carson
FRONTIERS IN IMMUNOLOGY (2021)
Dual mTORC1/2 inhibitor AZD2014 diminishes myeloid-derived suppressor cells accumulation in ovarian cancer and delays tumor growth
Ruyu Pi, Yang Yang, Xiaoyi Hu, Hongyi Li, Houhui Shi, Yu Liu, Xi Wang, An Tong, Tianqi Lu, Yuquan Wei, Xia Zhao, Xiawei Wei
CANCER LETTERS (2021)
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
Filippo Veglia, Ayumi Hashimoto, Harsh Dweep, Emilio Sanseviero, Alessandra De Leo, Evgenii Tcyganov, Andrew Kossenkov, Charles Mulligan, Brian Nam, Gregory Masters, Jaymala Patel, Vipul Bhargava, Patrick Wilkinson, Denis Smirnov, Manuel A. Sepulveda, Sunil Singhal, Evgeniy B. Eruslanov, Razvan Cristescu, Andrey Loboda, Yulia Nefedova, Dmitry I. Gabrilovich
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer
Morten F. F. Gjerstorff, Sofie Traynor, Odd L. L. Gammelgaard, Simone Johansen, Christina B. B. Pedersen, Henrik J. J. Ditzel, Mikkel G. G. Terp
CANCERS (2022)
PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
Mingxia Deng, Long Peng, Jiamin Li, Xiong Liu, Xichun Xia, Guangqiang Li
FRONTIERS IN GENETICS (2021)
LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer
Yifan Liu, Yukun Han, Yanhua Zhang, Tongtong Lv, Xiaochun Peng, Jinbai Huang
FRONTIERS IN IMMUNOLOGY (2023)
Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy
Michael R. Deyhle, Chandler S. Callaway, Daria Neyroud, Andrew C. D'Lugos, Sarah M. Judge, Andrew R. Judge
CELLS (2022)
Open Sesame to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer
Tian Wang, Yushu Hu, Silvia Dusi, Fang Qi, Silvia Sartoris, Stefano Ugel, Francesco De Sanctis
FRONTIERS IN IMMUNOLOGY (2023)
Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategies
Mohammad Salemizadeh Parizi, Fatemeh Salemizadeh Parizi, Saeed Abdolhosseini, Shohreh Vanaei, Ali Manzouri, Farnoosh Ebrahimzadeh
INFLAMMOPHARMACOLOGY (2021)
PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer
Mehdi Chaib, Laura M. M. Sipe, Johnathan R. R. Yarbro, Margaret S. S. Bohm, Brittany R. R. Counts, Ubaid Tanveer, Ajeeth K. K. Pingili, Deidre Daria, Tony N. N. Marion, James A. A. Carson, Paul G. G. Thomas, Liza Makowski
CANCER LETTERS (2022)
Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients
Kathryn E. Cole, Quan P. Ly, Michael A. Hollingsworth, Jesse L. Cox, Kurt W. Fisher, James C. Padussis, Jason M. Foster, Luciano M. Vargas, James E. Talmadge
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Demographic and clinical characteristics of extramammary Paget's disease patients in Japan from 2000 to 2019
F. M. Ghazawi, N. Iga, R. Tanaka, Y. Fujisawa, K. Yoshino, C. Yamashita, Y. Yamamoto, T. Fujimura, T. Yanagi, H. Hata, S. Matsushita, M. Le, S. F. Roy, F. Lagace, Y. Ishida, K. Kabashima, A. Otsuka
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanoma
Ryo Amagai, Taku Fujimura, Yusuke Muto, Yumi Kambayashi, Sadanori Furudate, Kentaro Ohuchi, Takami Okuma, Akira Hashimoto, Setsuya Aiba
DERMATOLOGIC THERAPY (2021)
Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma
Yusuke Muto, Taku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, Ryo Amagai, Takami Okuma, Sadanori Furudate, Akira Hashimoto, Setsuya Aiba
JOURNAL OF DERMATOLOGY (2021)
Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid
Kentaro Ohuchi, Taku Fujimura, Chunbing Lyu, Ryo Amagai, Yusuke Muto, Setsuya Aiba
JOURNAL OF DERMATOLOGY (2021)
Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: A case report
Mayuko Amagai, Maki Ozawa, Ryo Amagai, Kentaro Ohuchi, Yusuke Muto, Yumi Kambayashi, Setsuya Aiba, Taku Fujimura
DERMATOLOGIC THERAPY (2022)
Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy
Kentaro Ohuchi, Ryo Amagai, Erika Tamabuchi, Yumi Kambayashi, Taku Fujimura
JOURNAL OF DERMATOLOGY (2022)
Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance
Toshihisa Hamada, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Noriko Makita, Katsunori Manaka, Yoshihito Shimoyama, Makoto Sugaya
JOURNAL OF DERMATOLOGY (2022)
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers
Taku Fujimura
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
A pediatric case of corticosteroid-resistant erosive pustular dermatosis of scalp-like alopecia treated successfully with oral indomethacin, doxycycline, and topical tacrolimus
Rui Sasaki, Yoshihide Asano, Taku Fujimura
JOURNAL OF DERMATOLOGY (2022)
Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real-world case series
Ryo Amagai, Yumi Kambayashi, Kentaro Ohuchi, Sadanori Furudate, Akira Hashimoto, Yoshihide Asano, Taku Fujimura
DERMATOLOGIC THERAPY (2022)
Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas
Kentaro Ohuchi, Ryo Amagai, Tetsuya Ikawa, Yusuke Muto, Yuna Roh, Junko Endo, Takeo Maekawa, Yumi Kambayashi, Yoshihide Asano, Taku Fujimura
EXPERIMENTAL DERMATOLOGY (2023)
Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases
Taku Fujimura, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Yasuhiro Fujisawa, Shoichiro Ishizuki, Kojiro Segawa, Jun Yamamoto, Akira Hashimoto, Yumi Kambayashi, Yoshihide Asano
JOURNAL OF DERMATOLOGY (2023)
The significance of M1-polarized CD163+ macrophages in acute graft-versus-host disease (GVHD): Possible mechanisms of GVHD in the development of skin lesions
Yusuke Muto, Taku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, Chunbing Lyu, Hitoshi Terui, Masato Mizuashi, Setsuya Aiba, Yoshihide Asano
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY (2023)
Vogt-Koyanagi-Harada disease-like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA-DRB1*04
Ryo Amagai, Taku Fujimura, Emi Yamazaki, Manami Takahashi, Erika Tamabuchi, Yumi Kambayashi, Akira Hashimoto, Kazuki Hashimoto, Yoshihide Asano
JOURNAL OF DERMATOLOGY (2023)
Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol
Taku Fujimura, Koji Yoshino, Motoki Nakamura, Hiroshi Kato, Takamichi Ito, Takeo Maekawa, Yasuhiro Fujisawa, Shigeto Matsushita, Ryo Amagai, Emi Yamazaki, Manami Takahashi, Erika Tamabuchi, Akira Hashimoto, Yumi Kambayashi, Naoya Yamazaki, Toshio Miyata, Yoshihide Asano
EXPERIMENTAL DERMATOLOGY (2023)